Associate Venture Partners

Rosana Kapeller, M.D., Ph.D.
Rosana joined Apple Tree Partners in August 2005. She is currently Vice President, Research for Aileron Therapeutics. Prior to joining ATP, Rosana was Director of Molecular and Cellular Biology at Millennium Pharmaceuticals, Inc., where she played a key role in the functional evaluation and advancement of novel drug targets into Millennium's drug discovery pipeline. Rosana has published over 20 peer-reviewed scientific articles and is inventor/co-inventor on over 100 patents. Rosana completed her post-doctoral training in 1996 at the Dana Farber Cancer Institute with Dr. Stephen Burakoff where she was a recipient of the David Abraham Fellowship in Pediatric Oncology. She received her Ph.D. in 1994 from Tufts University under the supervision of Dr. Lewis C. Cantley. Rosana obtained her Medical Degree in 1986 from the Universidade de Ciências Médicas, Rio de Janeiro, Brazil.

Huw Nash, Ph.D.
Huw joined Apple Tree Partners in June 2005. He is currently Vice President, Corporate Development for Aileron Therapeutics. Prior to joining ATP, Huw was a founding scientist of NeoGenesis Pharmaceuticals, a drug-discovery technology company that was acquired by Schering-Plough in February 2005. At NeoGenesis, Huw served as Vice President, External Collaborations, where he directly managed 21 research collaborations with large pharma and biotech companies and academic labs, and also served as the principal technical representative for all business development, private financing and merger and acquisition activities. In addition, Huw was a Principal Investigator for three Small Business Innovation Research Grants, was a co-author of 5 peer-reviewed scientific publications with NeoGenesis, and was a co-inventor on 9 patents. Huw received his B.A. in Biochemical Sciences from Harvard College and received his Ph.D. in Organic Chemistry from Harvard University with Professor Gregory L. Verdine.